Cyclerion Therapeutics Stock Volatility

CYCN Stock  USD 3.08  0.05  1.65%   
We consider Cyclerion Therapeutics very risky. Cyclerion Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0141, which signifies that the company had a 0.0141% return per unit of standard deviation over the last 3 months. We have found twenty-four technical indicators for Cyclerion Therapeutics, which you can use to evaluate the volatility of the firm. Please confirm Cyclerion Therapeutics' mean deviation of 4.41, and Risk Adjusted Performance of (0) to double-check if the risk estimate we provide is consistent with the expected return of 0.1%. Key indicators related to Cyclerion Therapeutics' volatility include:
30 Days Market Risk
Chance Of Distress
30 Days Economic Sensitivity
Cyclerion Therapeutics Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Cyclerion daily returns, and it is calculated using variance and standard deviation. We also use Cyclerion's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Cyclerion Therapeutics volatility.
  
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as Cyclerion Therapeutics can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game. Here, they may decide to buy additional stocks of Cyclerion Therapeutics at lower prices. For example, an investor can purchase Cyclerion stock that has halved in price over a short period. This will lower your average cost per share, thereby improving your portfolio's performance when the markets normalize. Similarly, when the prices of Cyclerion Therapeutics' stock rises, investors can sell out and invest the proceeds in other equities with better opportunities. Investing when markets are volatile with better valuations will accord both investors and companies the opportunity to generate better long-term returns.

Moving against Cyclerion Stock

  0.75MRK Merck Company Fiscal Quarter End 31st of March 2024 PairCorr
  0.69DNTH Dianthus Therapeutics Symbol ChangePairCorr
  0.66MGNX MacroGenics Financial Report 14th of May 2024 PairCorr
  0.53EQ Equillium Financial Report 9th of May 2024 PairCorr
  0.51MDWD Mediwound Financial Report 4th of June 2024 PairCorr
  0.5URGN UroGen Pharma Financial Report 9th of May 2024 PairCorr

Cyclerion Therapeutics Market Sensitivity And Downside Risk

Cyclerion Therapeutics' beta coefficient measures the volatility of Cyclerion stock compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Cyclerion stock's returns against your selected market. In other words, Cyclerion Therapeutics's beta of 0.2 provides an investor with an approximation of how much risk Cyclerion Therapeutics stock can potentially add to one of your existing portfolios. Cyclerion Therapeutics is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Cyclerion Therapeutics' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Cyclerion Therapeutics' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.
3 Months Beta |Analyze Cyclerion Therapeutics Demand Trend
Check current 90 days Cyclerion Therapeutics correlation with market (NYSE Composite)

Cyclerion Beta

    
  0.2  
Cyclerion standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.

Standard Deviation

    
  7.39  
It is essential to understand the difference between upside risk (as represented by Cyclerion Therapeutics's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of Cyclerion Therapeutics' daily returns or price. Since the actual investment returns on holding a position in cyclerion stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in Cyclerion Therapeutics.

Cyclerion Therapeutics Stock Volatility Analysis

Volatility refers to the frequency at which Cyclerion Therapeutics stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Cyclerion Therapeutics' price changes. Investors will then calculate the volatility of Cyclerion Therapeutics' stock to predict their future moves. A stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Cyclerion Therapeutics' volatility:

Historical Volatility

This type of stock volatility measures Cyclerion Therapeutics' fluctuations based on previous trends. It's commonly used to predict Cyclerion Therapeutics' future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.

Implied Volatility

This type of volatility provides a positive outlook on future price fluctuations for Cyclerion Therapeutics' current market price. This means that the stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Cyclerion Therapeutics' to be redeemed at a future date.
Transformation
The output start index for this execution was zero with a total number of output elements of sixty-one. Cyclerion Therapeutics Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.

Cyclerion Therapeutics Projected Return Density Against Market

Given the investment horizon of 90 days Cyclerion Therapeutics has a beta of 0.1968 suggesting as returns on the market go up, Cyclerion Therapeutics average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Cyclerion Therapeutics will be expected to be much smaller as well.
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Cyclerion Therapeutics or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Cyclerion Therapeutics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Cyclerion stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Cyclerion Therapeutics has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming NYSE Composite.
   Predicted Return Density   
       Returns  
Cyclerion Therapeutics' volatility is measured either by using standard deviation or beta. Standard deviation will reflect the average amount of how cyclerion stock's price will differ from the mean after some time.To get its calculation, you should first determine the mean price during the specified period then subtract that from each price point.

What Drives a Cyclerion Therapeutics Price Volatility?

Several factors can influence a stock's market volatility:

Industry

Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.

Political and Economic environment

When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.

The Company's Performance

Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.

Cyclerion Therapeutics Stock Risk Measures

Given the investment horizon of 90 days the coefficient of variation of Cyclerion Therapeutics is 7114.84. The daily returns are distributed with a variance of 54.62 and standard deviation of 7.39. The mean deviation of Cyclerion Therapeutics is currently at 4.35. For similar time horizon, the selected benchmark (NYSE Composite) has volatility of 0.56
α
Alpha over NYSE Composite
-0.22
β
Beta against NYSE Composite0.20
σ
Overall volatility
7.39
Ir
Information ratio -0.04

Cyclerion Therapeutics Stock Return Volatility

Cyclerion Therapeutics historical daily return volatility represents how much of Cyclerion Therapeutics stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The firm inherits 7.3902% risk (volatility on return distribution) over the 90 days horizon. By contrast, NYSE Composite accepts 0.5731% volatility on return distribution over the 90 days horizon.
 Performance 
       Timeline  

About Cyclerion Therapeutics Volatility

Volatility is a rate at which the price of Cyclerion Therapeutics or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Cyclerion Therapeutics may increase or decrease. In other words, similar to Cyclerion's beta indicator, it measures the risk of Cyclerion Therapeutics and helps estimate the fluctuations that may happen in a short period of time. So if prices of Cyclerion Therapeutics fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.
Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system diseases. The company was incorporated in 2018 and is headquartered in Cambridge, Massachusetts. Cyclerion Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 32 people.
Cyclerion Therapeutics' stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on Cyclerion Stock over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much Cyclerion Therapeutics' price varies over time.

3 ways to utilize Cyclerion Therapeutics' volatility to invest better

Higher Cyclerion Therapeutics' stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of Cyclerion Therapeutics stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. Cyclerion Therapeutics stock volatility can provide helpful information for making investment decisions in the following ways:
  • Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of Cyclerion Therapeutics investment. A higher volatility means higher risk and potentially larger changes in value.
  • Identifying Opportunities: High volatility in Cyclerion Therapeutics' stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
  • Diversification: Understanding how the volatility of Cyclerion Therapeutics' stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
Remember it's essential to remember that stock volatility is just one of many factors to consider when making investment decisions, and it should be used in conjunction with other fundamental and technical analysis tools.

Cyclerion Therapeutics Investment Opportunity

Cyclerion Therapeutics has a volatility of 7.39 and is 12.96 times more volatile than NYSE Composite. 65 percent of all equities and portfolios are less risky than Cyclerion Therapeutics. You can use Cyclerion Therapeutics to enhance the returns of your portfolios. The stock experiences a large bullish trend. Check odds of Cyclerion Therapeutics to be traded at $3.39 in 90 days.

Significant diversification

The correlation between Cyclerion Therapeutics and NYA is 0.01 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Cyclerion Therapeutics and NYA in the same portfolio, assuming nothing else is changed.

Cyclerion Therapeutics Additional Risk Indicators

The analysis of Cyclerion Therapeutics' secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Cyclerion Therapeutics' investment and either accepting that risk or mitigating it. Along with some common measures of Cyclerion Therapeutics stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Cyclerion Therapeutics Suggested Diversification Pairs

Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Cyclerion Therapeutics as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Cyclerion Therapeutics' systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Cyclerion Therapeutics' unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Cyclerion Therapeutics.
When determining whether Cyclerion Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cyclerion Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cyclerion Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cyclerion Therapeutics Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cyclerion Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.
To learn how to invest in Cyclerion Stock, please use our How to Invest in Cyclerion Therapeutics guide.
Note that the Cyclerion Therapeutics information on this page should be used as a complementary analysis to other Cyclerion Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Complementary Tools for Cyclerion Stock analysis

When running Cyclerion Therapeutics' price analysis, check to measure Cyclerion Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cyclerion Therapeutics is operating at the current time. Most of Cyclerion Therapeutics' value examination focuses on studying past and present price action to predict the probability of Cyclerion Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cyclerion Therapeutics' price. Additionally, you may evaluate how the addition of Cyclerion Therapeutics to your portfolios can decrease your overall portfolio volatility.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Stocks Directory
Find actively traded stocks across global markets
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Is Cyclerion Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cyclerion Therapeutics. If investors know Cyclerion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cyclerion Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(5.39)
Revenue Per Share
0.586
Quarterly Revenue Growth
0.141
Return On Assets
(0.38)
Return On Equity
(1.16)
The market value of Cyclerion Therapeutics is measured differently than its book value, which is the value of Cyclerion that is recorded on the company's balance sheet. Investors also form their own opinion of Cyclerion Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Cyclerion Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cyclerion Therapeutics' market value can be influenced by many factors that don't directly affect Cyclerion Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cyclerion Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cyclerion Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cyclerion Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.